期刊
ACS INFECTIOUS DISEASES
卷 7, 期 1, 页码 23-33出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.0c00337
关键词
Pseudomonas aeruginosa; antibiotic resistance; nitric oxide; synergy; biofilm
资金
- Cystic Fibrosis Foundation [Schoen18G0]
Antibiotic resistance in bacteria is a major global threat, especially for patients with cystic fibrosis who are frequently colonized by multidrug-resistant species. Research has shown that nitric oxide can act as a broad-spectrum antibacterial agent, improving the effectiveness of conventional antibiotics and slowing the development of antibiotic resistance.
Antibiotic resistance in bacteria is a major global threat and a leading cause for healthcare-related morbidity and mortality. Resistant biofilm infections are particularly difficult to treat owing to the protective biofilm matrix, which decreases both antibiotic efficacy and clearance by the host. Novel antimicrobial agents that are capable of eradicating resistant infections are greatly needed to combat the rise of antibiotic-resistant bacteria, particularly in patients with cystic fibrosis who are frequently colonized by multidrug-resistant species. Our research group has developed nitric oxide-releasing biopolymers as alternatives to conventional antibiotics. Here, we show that nitric oxide acts as a broad-spectrum antibacterial agent while also improving the efficacy of conventional antibiotics when delivered sequentially. Alone, nitric oxide kills a broad range of bacteria in planktonic and biofilm form without engendering resistance. In combination with conventional antibiotics, nitric oxide increases bacterial susceptibility to multiple classes of antibiotics and slows the development of antibiotic resistance. We anticipate that the use of nitric oxide in combination with antibiotics may improve the outcome of patients with refractory infections, particularly those that are multidrug-resistant.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据